A detailed history of Capital Square, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capital Square, LLC holds 12,768 shares of PFE stock, worth $336,564. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,768
Previous 12,414 2.85%
Holding current value
$336,564
Previous $347,000 6.34%
% of portfolio
0.23%
Previous 0.23%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $9,805 - $11,112
354 Added 2.85%
12,768 $369,000
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $11,947 - $14,000
473 Added 3.96%
12,414 $347,000
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $5,411 - $6,213
209 Added 1.78%
11,941 $331,000
Q4 2023

Jan 26, 2024

SELL
$26.13 - $33.94 $109,746 - $142,548
-4,200 Reduced 26.36%
11,732 $337,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $40,112 - $46,887
-1,250 Reduced 7.28%
15,932 $528,000
Q2 2023

Aug 07, 2023

BUY
$36.12 - $41.79 $19,251 - $22,274
533 Added 3.2%
17,182 $630,000
Q1 2023

Apr 24, 2023

BUY
$39.39 - $51.28 $27,336 - $35,588
694 Added 4.35%
16,649 $679,000
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $194,054 - $253,316
-4,648 Reduced 22.56%
15,955 $817,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $84,631 - $103,314
-1,934 Reduced 8.58%
20,603 $901,000
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $298,071 - $353,419
-6,406 Reduced 22.13%
22,537 $1.18 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $114,420 - $141,781
-2,501 Reduced 7.95%
28,943 $1.5 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $74,458 - $110,372
-1,802 Reduced 5.42%
31,444 $1.75 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $56,755 - $72,907
-1,446 Reduced 4.17%
33,246 $1.43 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $280,852 - $318,158
7,821 Added 29.11%
34,692 $1.42 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $14,434 - $16,278
-431 Reduced 1.58%
26,871 $983,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $66,437 - $84,481
1,985 Added 7.84%
27,302 $1 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $31 - $37
-1 Reduced -0.0%
25,317 $929,000
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $66,675 - $78,225
2,100 Added 9.04%
25,318 $929,000
Q2 2020

Jul 27, 2020

BUY
$30.12 - $36.54 $32,138 - $38,988
1,067 Added 4.82%
23,218 $759,000
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $89,144 - $127,368
3,298 Added 17.49%
22,151 $723,000
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $620,640 - $704,348
18,853 New
18,853 $738,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Square, LLC Portfolio

Follow Capital Square, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Square, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Square, LLC with notifications on news.